Condition: BK Virus Infection · Sponsor: University Hospital, Strasbourg, France
BK virus (BKV) infection has a major negative impact on transplant recipients. No BKV-specific antiviral therapy is available, so there is an urgent need to develop new anti-BKV preventive and therapeutic strategies.
This description comes directly from the study's public registry record.
Anne-Sophie U GEY · +33 388116684 · anne-sophie.gey@chru-strasbourg.fr
Always discuss trial participation with your own doctor first.
| Service de Virologie - CHU Strasbourg - France | Strasbourg, France | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05264259